To p(53) or not to p(53): interview with Dr. Mariam Nawas

Update: 2024-04-24

Description

What a delight to have Dr. Mariam Nawas of the University of Chicago join us for a round-up of her favorite abstracts from Tandem 2024! We also discussed her recent and controversial review "Utility or futility? A contemporary approach to allogeneic hematopoietic cell transplantation for TP53-mutated MDS/AML", which appeared in Blood Advances earlier this year.

Hosted on Acast. See acast.com/privacy for more information.

Comments

In Channel

Season 2 premiere! CLL and Richter's Transformation with Dr. Adam Kittai

2024-09-0958:07

Episode 6 - Thinking Meta about CAR Mortality with David Cordas dos Santos and Kai Rejeski

2024-07-2253:59

Episode 5 - Transplant Strikes Back... immediately! The ASAP trial takes on active disease

2024-05-2801:18:20

To p(53) or not to p(53): interview with Dr. Mariam Nawas

2024-04-2454:46

CARpe diem! Lymphoma CAR-T roundup with Dr. Sam Yamshon

2024-04-0101:02:40

ICAHT Take It Anymore!

2024-03-1101:02:16

Episode 1! Off to Tandem 24

2024-02-1923:55

00:00

1.0x

#box-pro-ellipsis-175885640251444{-webkit-line-clamp:2;}To p(53) or not to p(53): interview with Dr. Mariam Nawas